• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在食管鳞状细胞癌中,PLK1的过表达通过提高生存素水平抑制细胞凋亡,从而与较差的生存率相关。

Overexpression of PLK1 is associated with poor survival by inhibiting apoptosis via enhancement of survivin level in esophageal squamous cell carcinoma.

作者信息

Feng Yan-Bin, Lin De-Chen, Shi Zhi-Zhou, Wang Xiao-Chun, Shen Xiao-Ming, Zhang Yu, Du Xiao-Li, Luo Man-Li, Xu Xin, Han Ya-Ling, Cai Yan, Zhang Zi-Qiang, Zhan Qi-Min, Wang Ming-Rong

机构信息

State Key Laboratory of Molecular Oncology, Cancer Institute Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.

出版信息

Int J Cancer. 2009 Feb 1;124(3):578-88. doi: 10.1002/ijc.23990.

DOI:10.1002/ijc.23990
PMID:19004025
Abstract

PLK1 is essential for the maintenance of genomic stability during mitosis. In our study, we found that overexpression of PLK1 was an independent prognostic factor (RR=4.253, p=0.020) and significantly correlated with survivin, an antiapoptotic protein, in esophageal squamous cell carcinoma (ESCC). Reverse transcription-polymerase chain reaction and fluorescence in situ hybridization (FISH) revealed upregulation of PLK1 mRNA and amplification of PLK1 gene, respectively. Depletion of PLK1 activated the intrinsic apoptotic pathway, which was substantiated by loss of mitochondrial membrane potential, reduction of Mcl-1 and Bcl-2 as well as activation of caspase-9. Coimmunoprecipitation and confocal microscopy displayed that PLK1 was associated with survivin and PLK1 depletion led to downregulation of survivin. Cotransfection of survivin constructs could partially reverse PLK1-depletion-induced apoptosis. These data suggest that PLK1 might be a useful prognostic marker and a potential therapeutic target for ESCC. Survivin is probably involved in antiapoptotic function of PLK1.

摘要

PLK1对于有丝分裂期间基因组稳定性的维持至关重要。在我们的研究中,我们发现PLK1的过表达是食管鳞状细胞癌(ESCC)中的一个独立预后因素(RR = 4.253,p = 0.020),并且与抗凋亡蛋白survivin显著相关。逆转录-聚合酶链反应和荧光原位杂交(FISH)分别揭示了PLK1 mRNA的上调和PLK1基因的扩增。PLK1的缺失激活了内源性凋亡途径,这通过线粒体膜电位的丧失、Mcl-1和Bcl-2的减少以及caspase-9的激活得到证实。免疫共沉淀和共聚焦显微镜显示PLK1与survivin相关,并且PLK1的缺失导致survivin的下调。survivin构建体的共转染可以部分逆转PLK1缺失诱导的凋亡。这些数据表明PLK1可能是ESCC的一个有用的预后标志物和潜在的治疗靶点。Survivin可能参与了PLK1的抗凋亡功能。

相似文献

1
Overexpression of PLK1 is associated with poor survival by inhibiting apoptosis via enhancement of survivin level in esophageal squamous cell carcinoma.在食管鳞状细胞癌中,PLK1的过表达通过提高生存素水平抑制细胞凋亡,从而与较差的生存率相关。
Int J Cancer. 2009 Feb 1;124(3):578-88. doi: 10.1002/ijc.23990.
2
Reciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cells.PLK1 和 Stat3 之间的相互激活促进食管癌细胞的存活和增殖。
Gastroenterology. 2012 Mar;142(3):521-530.e3. doi: 10.1053/j.gastro.2011.11.023. Epub 2011 Nov 19.
3
Survivin in esophageal cancer: An accurate prognostic marker for squamous cell carcinoma but not adenocarcinoma.食管癌中的生存素:鳞状细胞癌的准确预后标志物,而非腺癌的预后标志物。
Int J Cancer. 2006 Oct 1;119(7):1717-22. doi: 10.1002/ijc.21923.
4
Polo-like kinase 1 contributes to the tumorigenicity of BEL-7402 hepatoma cells via regulation of Survivin expression.Polo-like kinase 1 通过调节 Survivin 表达促进 BEL-7402 肝癌细胞的致瘤性。
Cancer Lett. 2011 Apr 28;303(2):92-8. doi: 10.1016/j.canlet.2011.01.007. Epub 2011 Feb 16.
5
Immunohistochemical analysis of nuclear survivin expression in esophageal squamous cell carcinoma.食管鳞状细胞癌中核存活素表达的免疫组织化学分析
Dis Esophagus. 2006;19(5):355-9. doi: 10.1111/j.1442-2050.2006.00604.x.
6
Overexpression of Plk1 promotes malignant progress in human esophageal squamous cell carcinoma.Plk1 的过表达促进人食管鳞癌细胞的恶性进展。
J Cancer Res Clin Oncol. 2010 Jan;136(1):9-16. doi: 10.1007/s00432-009-0630-4.
7
Polo-like kinase and survivin are esophageal tumor-specific promoters.Polo样激酶和生存素是食管肿瘤特异性启动子。
Biochem Biophys Res Commun. 2006 Apr 7;342(2):465-71. doi: 10.1016/j.bbrc.2006.01.177. Epub 2006 Feb 9.
8
Silencing of polo-like kinase (Plk) 1 via siRNA causes inhibition of growth and induction of apoptosis in human esophageal cancer cells.通过小干扰RNA(siRNA)使polo样激酶(Plk)1沉默可导致人食管癌细胞生长受抑制并诱导其凋亡。
Oncology. 2008;74(3-4):198-206. doi: 10.1159/000151367. Epub 2008 Aug 20.
9
PLK1 Is transcriptionally activated by NF-κB during cell detachment and enhances anoikis resistance through inhibiting β-catenin degradation in esophageal squamous cell carcinoma.PLK1 在细胞脱离时被 NF-κB 转录激活,并通过抑制食管鳞状细胞癌细胞中 β-连环蛋白的降解来增强抗失巢凋亡能力。
Clin Cancer Res. 2011 Jul 1;17(13):4285-95. doi: 10.1158/1078-0432.CCR-10-3236. Epub 2011 May 24.
10
SnoN overexpression is predictive of poor survival in patients with esophageal squamous cell carcinoma.SnoN过表达预示食管鳞状细胞癌患者的生存预后较差。
Ann Surg Oncol. 2008 Oct;15(10):2965-75. doi: 10.1245/s10434-008-9986-y. Epub 2008 Jul 9.

引用本文的文献

1
MLN0905, a new inhibitor of Polo-like kinase 1 (PLK1), enhances the efficiency of lenalidomide in promoting the apoptosis of multiple myeloma cell lines.MLN0905,一种新型的Polo样激酶1(PLK1)抑制剂,可提高来那度胺促进多发性骨髓瘤细胞系凋亡的效率。
Invest New Drugs. 2025 Apr;43(2):348-356. doi: 10.1007/s10637-025-01531-w. Epub 2025 Apr 25.
2
Emerging Role of the DREAM Complex in Cancer and Therapeutic Opportunities.DREAM复合物在癌症中的新作用及治疗机会
Int J Mol Sci. 2025 Jan 1;26(1):322. doi: 10.3390/ijms26010322.
3
Polo-like Kinase 1 Predicts Lymph Node Metastasis in Middle Eastern Colorectal Cancer Patients; Its Inhibition Reverses 5-Fu Resistance in Colorectal Cancer Cells.
Polo-like Kinase 1 预测中东结直肠癌患者的淋巴结转移;其抑制作用可逆转结直肠癌细胞对 5-Fu 的耐药性。
Cells. 2024 Oct 14;13(20):1700. doi: 10.3390/cells13201700.
4
Integrating network analysis with differential expression to uncover therapeutic and prognostic biomarkers in esophageal squamous cell carcinoma.整合网络分析与差异表达以揭示食管鳞状细胞癌的治疗和预后生物标志物。
Front Mol Biosci. 2024 Aug 21;11:1425422. doi: 10.3389/fmolb.2024.1425422. eCollection 2024.
5
AKT Inhibition Sensitizes to Polo-Like Kinase 1 Inhibitor Onvansertib in Prostate Cancer.AKT 抑制增强前列腺癌细胞对 Polo 样激酶 1 抑制剂 Onvansertib 的敏感性。
Mol Cancer Ther. 2024 Oct 1;23(10):1404-1417. doi: 10.1158/1535-7163.MCT-23-0933.
6
HuaChanSu suppresses the growth of hepatocellular carcinoma cells by interfering with pentose phosphate pathway through down-regulation of G6PD enzyme activity and expression.华蟾素通过下调葡萄糖-6-磷酸脱氢酶(G6PD)的酶活性和表达来干扰磷酸戊糖途径,从而抑制肝癌细胞的生长。
Heliyon. 2024 Jan 26;10(3):e25144. doi: 10.1016/j.heliyon.2024.e25144. eCollection 2024 Feb 15.
7
The oncogenic mechanisms of the Janus kinase-signal transducer and activator of transcription pathway in digestive tract tumors.Janus激酶-信号转导与转录激活因子通路在消化道肿瘤中的致癌机制。
Cell Commun Signal. 2024 Jan 25;22(1):68. doi: 10.1186/s12964-023-01421-9.
8
Identification of FKBP10 prognostic value in lung adenocarcinoma patients with surgical resection of brain metastases: A retrospective single-institution cohort study.鉴定 FKBP10 在手术切除脑转移的肺腺癌患者中的预后价值:一项回顾性单机构队列研究。
Clinics (Sao Paulo). 2023 May 16;78:100212. doi: 10.1016/j.clinsp.2023.100212. eCollection 2023.
9
PLK1 inhibition promotes apoptosis and DNA damage in glioma stem cells by regulating the nuclear translocation of YBX1.PLK1抑制通过调节YBX1的核转位促进胶质瘤干细胞的凋亡和DNA损伤。
Cell Death Discov. 2023 Feb 17;9(1):68. doi: 10.1038/s41420-023-01302-7.
10
The kinase PLK1 promotes the development of /-mutant lung adenocarcinoma through transcriptional activation of the receptor RET.激酶 PLK1 通过转录激活受体 RET 促进 /- 突变型肺腺癌的发展。
Sci Signal. 2022 Oct 4;15(754):eabj4009. doi: 10.1126/scisignal.abj4009.